<
Xia Chuantao, the director of Beilin Pharmaceutical Business Development Director Xia Chuantao and his party stake sports betting appstake online sports bettingwent to Shaanxi Pharmaceutical Research Institute for discussion and exchange
Release time: 2023-01-18 & nbsp & nbsp & nbsp Source: Research Institute

January 12,Xi'an Beilin Pharmaceutical Co., Ltd. (hereinafter referred to as "Beilin Pharmaceutical") business expansion director Xia Chuantao and his team visited Shaanxi Medical Holding Medical Research Institute Co., Ltd. (hereinafter referred to as "Shaanxi Pharmaceutical Research Institute"),Both sides are scientific research cooperation、Resource sharing and other aspects of discussions and exchanges。Dean of Shaanxi Pharmaceutical Research Institute Li Xiaojie、Executive Deputy Dean Cao Ailan and other relevant personnel accompanied the discussion。

 Picture 1_PNG

Over the meeting,Li Xiaojie welcomes Xia Chuantao's visits,and briefly for the Shaanxi Pharmaceutical Research stake sports betting appInstitute、Technology resources、Stake Sports BettingTalent Team、Scientific and technological achievements、Trial workshop, Introduced, introduced。Xia Chuantao introduced the development history of Beilin Pharmaceutical、Research project、Product advantage、Market sales, etc.。Li Xiaojie pointed out,Both parties have their own characteristics in the production and sales of Chinese medicines and product development,Should make full use of their respective scientific and technological resources,complementary advantages、Win -win cooperation。Xia Chuantao said,Shaanxi Pharmaceutical Research Institute has strong R & D strength and professional talent team,Beilin Pharmaceuticals Wishes to conduct in -depth cooperation with Shaanxi Pharmaceutical Research Institute,Promoting common development。Then the two stake sports betting appparties launched an in -depth exchange on the cooperative project。

 Picture 2_D.png

After the meeting,Xia Chuantao and his party visited the Trial Workshop and Laboratory of the High School of Shaanxi Pharmaceutical Research Institute。